125 related articles for article (PubMed ID: 8854674)
1. An unusual case of multiple endocrine neoplasia type 1 and the role of 111In-pentetreotide scintigraphy.
Ponssen HH; de Herder WW; Bonjer HJ; Wauters CC; Krenning EP; Lamberts SW
Neth J Med; 1996 Sep; 49(3):112-5. PubMed ID: 8854674
[TBL] [Abstract][Full Text] [Related]
2. Multiple endocrine neoplastic-associated thymic carcinoid tumour in close relatives: octreotide scan as a new diagnostic and follow-up modality. Two case reports.
Satta J; Ahonen A; Parkkila S; Leinonen L; Apaja-Sarkkinen M; Lepojärvi M; Juvonen T
Scand Cardiovasc J; 1999; 33(1):49-53. PubMed ID: 10093860
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin-receptor scintigraphy in the management of gastroenteropancreatic tumors.
Krausz Y; Bar-Ziv J; de Jong RB; Ish-Shalom S; Chisin R; Shibley N; Glaser B
Am J Gastroenterol; 1998 Jan; 93(1):66-70. PubMed ID: 9448177
[TBL] [Abstract][Full Text] [Related]
4. Neuroendocrine tumors and somatostatin: imaging techniques.
de Herder WW; Kwekkeboom DJ; Valkema R; Feelders RA; van Aken MO; Lamberts SW; van der Lely AJ; Krenning EP
J Endocrinol Invest; 2005; 28(11 Suppl International):132-6. PubMed ID: 16625862
[TBL] [Abstract][Full Text] [Related]
5. Per operative localization of a carcinoid tumour of the breast using indium-111 pentetreotide and a nuclear surgical probe.
Meunier B; Le Cloirec J; Dazord L; Leveque J; Lesimple T; Tas P; Bourguet P
Eur J Nucl Med; 1995 Mar; 22(3):281-3. PubMed ID: 7789401
[TBL] [Abstract][Full Text] [Related]
6. Multicentric carcinoid tumor of the ileum localized by radioguided laparotomy.
de la Ossa M; Smoak W; Willis I; Robinson MJ
Clin Nucl Med; 2001 Jul; 26(7):649. PubMed ID: 11416759
[No Abstract] [Full Text] [Related]
7. Use of In-111 pentetreotide scintigraphy in the diagnosis of a midgut carcinoid causing Cushing's syndrome.
Segu VB; Mahvi DM; Wilson MA; Hale SJ; Warner TF; Meredith M; Shenker Y
Eur J Endocrinol; 1997 Jul; 137(1):79-83. PubMed ID: 9242206
[TBL] [Abstract][Full Text] [Related]
8. 111In-octreotide scintigraphy in endocrine tumors. Preliminary data.
Cremonini N; Furno A; Sforza A; Chiarini V; Graziano E; Zampa G; Turba E
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):116-20. PubMed ID: 9002767
[TBL] [Abstract][Full Text] [Related]
9. OctreoScan positive Crohn's disease mimicking an ileal carcinoid tumor.
Marko J; Lamba R; Miller F; Buchman A; Spies S; Nikolaidis P
J Clin Gastroenterol; 2008 Jan; 42(1):66-8. PubMed ID: 18097293
[TBL] [Abstract][Full Text] [Related]
10. A metastatic neuroendocrine anaplastic small cell tumor in a patient with multiple endocrine neoplasia type 1 syndrome. Assessment of disease status and response to doxorubicin, cyclophosphamide, etoposide chemotherapy through scintigraphic imaging with 111In-pentetreotide.
O'Byrne KJ; Goggins MG; McDonald GS; Daly PA; Kelleher DP; Weir DG
Cancer; 1994 Oct; 74(8):2374-8. PubMed ID: 7922988
[TBL] [Abstract][Full Text] [Related]
11. Multiple endocrine neoplasia type 1: scintigraphic and magnetic resonance demonstration.
Nguyen BD; Wang EA
Clin Nucl Med; 1999 Jan; 24(1):73-4. PubMed ID: 9890506
[No Abstract] [Full Text] [Related]
12. Improved visualization of carcinoid liver metastases by indium-111 pentetreotide scintigraphy following treatment with cold somatostatin analogue.
Dörr U; Räth U; Sautter-Bihl ML; Guzman G; Bach D; Adrian HJ; Bihl H
Eur J Nucl Med; 1993 May; 20(5):431-3. PubMed ID: 8100192
[TBL] [Abstract][Full Text] [Related]
13. Imaging of a mediastinal thymic carcinoid tumor with radiolabeled somatostatin analogue.
Cadigan DG; Hollett PD; Collingwood PW; Ur E
Clin Nucl Med; 1996 Jun; 21(6):487-8. PubMed ID: 8744192
[No Abstract] [Full Text] [Related]
14. [Bone metastasis from gastrinoma without hepatic involvement. Utility of the scintigraphy with 111 In-pentetreotide].
Cortés M; Mora J; Benítez A; González MJ; Castell M; Martín-Comín J
Rev Esp Med Nucl; 2001 Feb; 20(1):23-6. PubMed ID: 11181326
[TBL] [Abstract][Full Text] [Related]
15. Carcinoid tumours presenting as breast cancer: the utility of radionuclide imaging with 123I-MIBG and 111In-DTPA pentetreotide.
Kaltsas GA; Putignano P; Mukherjee JJ; Satta MA; Lowe DG; Britton KE; Monson JP; Grossman AB; Besser GM
Clin Endocrinol (Oxf); 1998 Nov; 49(5):685-9. PubMed ID: 10197087
[TBL] [Abstract][Full Text] [Related]
16. Combined diagnostic imaging with 131I-metaiodobenzylguanidine and 111In-pentetreotide in carcinoid tumours.
Taal BG; Hoefnagel CA; Valdés Olmos RA; Boot H
Eur J Cancer; 1996 Oct; 32A(11):1924-32. PubMed ID: 8943676
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin-receptor scintigraphy of subcutaneous and thyroid metastases from bronchial carcinoid.
Krausz Y; Pfeffer MR; Glaser B; Lafair J
J Nucl Med; 1996 Sep; 37(9):1537-9. PubMed ID: 8790214
[TBL] [Abstract][Full Text] [Related]
18. Comparative studies on the expression of somatostatin receptor subtypes, outcome of octreotide scintigraphy and response to octreotide treatment in patients with carcinoid tumours.
Nilsson O; Kölby L; Wängberg B; Wigander A; Billig H; William-Olsson L; Fjälling M; Forssell-Aronsson E; Ahlman H
Br J Cancer; 1998 Feb; 77(4):632-7. PubMed ID: 9484822
[TBL] [Abstract][Full Text] [Related]
19. Comment on primary localization of an ectopic ACTH-producing bronchial carcinoid tumor by indium111 pentetreotide scintigraphy.
Reincke M; Allolio B; Arlt W; Körber C
J Clin Endocrinol Metab; 1999 Sep; 84(9):3399-400; author reply 3402-3. PubMed ID: 10487718
[No Abstract] [Full Text] [Related]
20. Whole body and tomographic scan with 111In-pentetreotide: preliminary data.
Gregianin M; Macrì C; Bui F; Varotto L; Zucchetta P
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):124-6. PubMed ID: 9002769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
